Original language | English (US) |
---|---|
Pages (from-to) | S321-S322 |
Journal | HPB |
Volume | 25 |
DOIs | |
State | Published - Jan 1 2023 |
Utilization of Atezolizumab Plus Bevacizumab as Subsequent-line Therapy in Patients with Unresectable Hepatocellular Carcinoma: Abstracts of the 15th Biennial Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), 6-9 June 2023, Lyon, France.
A. Abudayyeh, A. Esmail, A. Kaseb, J. Xu, G. Umoru, K. Abboud, M. Abdelrahim
Research output: Contribution to journal › Article › peer-review